top-banner

METHODS AND TECHNOLOGIES

Cell free DNA (cfDNA) Analysis

cfDNA ANALYSIS

DNA is found primarily in the cell nucleus, where it exists in a linear form, in protein complexes. To study this nuclear DNA, cells must be broken open, and the DNA purified. However, DNA also circulates in the bloodstream outside of cells, known as cell-free DNA (cfDNA). This cfDNA can be easily collected through plasma separation without the need for cell lysis.


Cell-free DNA originates from apoptotic (programmed cell death) processes occurring throughout the body. During apoptosis, genomic DNA is fragmented and released into the bloodstream. Various cell types, including fat cells (adipocytes), placental cells, tumor cells, and transplanted cells, contribute to cfDNA when they undergo apoptosis. Although “foreign” cfDNA makes up a small fraction of the total cfDNA in the blood, it can be analyzed to detect placental aneuploidy, cancer-specific variants, and conditions like graft-versus-host disease (GvHD).

Real-time PCR

This technique uses allele-specific probes for targeted detection of pathogenic variants, particularly those on the Y chromosome. It can also detect duplications or deletions through relative quantification.

Droplet digital PCR (ddPCR)

ddPCR involves massive parallel partitioning a PCR mixture into thousands of tiny oil droplets, effectively diluting the starting material. This method offers high sensitivity and enables absolute quantification of cfDNA. It can distinguish between maternal and placental cfDNA and is used to detect point mutations, copy number variations (CNVs), loss of heterozygosity, and aneuploidy.

Shotgun sequencing

Shotgun sequencing, like ddPCR, can detect point mutations, CNVs, loss of heterozygosity, and aneuploidy in cfDNA. It also allows for whole-genome sequencing of the placental genome, making it a powerful tool for comprehensive analysis.

Mass spectrometry

MALDI-TOF MS can be used to sequence point mutations in cfDNA. In this process, an oligonucleotide binds just before the site of the point mutation and is extended by a single nucleotide (single nucleotide sequencing). Differences in mass allow for differentiation between homozygous and heterozygous base pair positions.

WAYS TO PARTNER WITH US

TarCET IVD Kits

CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form

Learn more

Technology Transfer

Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing

Learn more

Genetic Testing Laboratory

Your partner for
all genetic tests

Learn more

Contact Us

Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.

Learn more

BLOG ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact …

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc…

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of …

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access…

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is…

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti…

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati…

Read more

OUR NETWORK